4//SEC Filing
Batlin Judy A 4
Accession 0001209191-10-020347
CIK 0001012140other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 6:42 PM ET
Size
10.6 KB
Accession
0001209191-10-020347
Insider Transaction Report
Form 4
Batlin Judy A
VP, Org Learning, Dvlpmnt & HR
Transactions
- Sale
Common Stock
2010-04-01$30.30/sh−1$30→ 15,148 total - Sale
Common Stock
2010-04-01$30.10/sh−493$14,839→ 15,149 total - Award
Stock Option (Right to Buy)
2010-03-31+31,500→ 31,500 totalExercise: $30.28Exp: 2020-03-31→ Common Stock (31,500 underlying) - Award
Common Stock
2010-03-31+4,500→ 15,642 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]12.5% of the shares subject to the option become exercisable 6 months following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months.
Documents
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeother
Related Parties
1- filerCIK 0001447317
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 6:42 PM ET
- Size
- 10.6 KB